sophia genetics, world's largest clinical genomics community, brings together expertise in genetics, bioinformatics, machine learning and genomic privacy. based in switzerland, we are known for our high medical standards and swiss precision. sophia genetics offers health professionals who perform clinical genetic testing unparalleled bioinformatics analysis, quality assurance and secure banking of patient dna sequence data generated by ngs. the company helps clinical laboratories to reduce costs, overcome complexity, significantly improve the turnaround time for routine diagnosis and meet quality requirements related to the use of ngs in the clinic. our solution, the sophia ddm™ platform allows hospitals to better and faster diagnose patients using cutting edge ngs analytics algorithms and through knowledge sharing within the largest clinical genomics community in the world (+100 hospitals). the name « sophia » means wisdom in greek and it is the definition of our excellence based
Company profile
Ticker
SOPH
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
for purposes of broadening the shareholder constituency of the Company • following a shareholder or a group • if the issuance occurs in domestic or international • To the extent that the advance subscription rights are withdrawn or limited • dissolving a company • A shareholder of a Swiss corporation • the ultimate direction of the business of the Company • the ultimate supervision of those persons entrusted with management of the Company • The obligation of any person or group • The Depository Trust Company ...
SOPH stock data
Latest filings (excl ownership)
20-F
2023 FY
Annual report (foreign)
5 Mar 24
6-K
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
5 Mar 24
6-K
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
10 Jan 24
6-K
Index to Consolidated Financial Statements
7 Nov 23
6-K
The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting edge science
18 Oct 23
6-K
Current report (foreign)
14 Aug 23
6-K
Current report (foreign)
8 Aug 23
424B5
Prospectus supplement for primary offering
8 Aug 23
6-K
Index to Consolidated Financial Statements
8 Aug 23
6-K
Current report (foreign)
27 Jun 23
Latest ownership filings
144
Notice of proposed sale of securities
19 Apr 24
144
Notice of proposed sale of securities
19 Apr 24
144
Notice of proposed sale of securities
19 Apr 24
144
Notice of proposed sale of securities
19 Apr 24
144
Notice of proposed sale of securities
19 Apr 24
144
Notice of proposed sale of securities
19 Apr 24
144
Notice of proposed sale of securities
10 Apr 24
144
Notice of proposed sale of securities
10 Apr 24
144
Notice of proposed sale of securities
10 Apr 24
144
Notice of proposed sale of securities
10 Apr 24
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Institutional ownership, Q3 2023
49.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 34 |
Opened positions | 2 |
Closed positions | 5 |
Increased positions | 9 |
Reduced positions | 10 |
13F shares | Current |
---|---|
Total value | 43.21 bn |
Total shares | 32.01 mm |
Total puts | 100.00 |
Total calls | 100.00 |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
Marc Coucke | 6.99 mm | $98.61 mm |
Generation Investment Management | 6.79 mm | $17.31 bn |
Yair Chaim Schindel | 4.74 mm | $20.15 mm |
Balderton Capital VI, S.L.P. | 3.36 mm | $47.40 mm |
Banque Pictet & Cie | 2.24 mm | $5.71 bn |
Credit Suisse | 2.03 mm | $5.18 bn |
Millennium Management | 1.93 mm | $4.93 bn |
Alta Wealth Advisors | 1.41 mm | $3.59 bn |
PFG Principal Financial Group Inc - Registered Shares | 970.66 k | $2.48 bn |
BLK Blackrock | 298.67 k | $760.12 mm |
News
SOPHiA GENETICS And Strand Life Sciences Enter New Strategic Partnership, To Advance The Use Of Precision Medicine
4 Apr 24
SOPHiA GENETICS Announces First Homologous Recombination Deficiency Customer in Canada
20 Mar 24
12 Health Care Stocks Moving In Monday's After-Market Session
18 Mar 24
SOPHiA Genetics And The French Kidney Cancer Research Network (UroCCR) Publish Results From Multiyear Collaboration On A Study Using A Multimodal Algorithm To Predict Post-operative Outcomes For Those Facing Renal Cell Carcinoma
15 Mar 24
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
6 Mar 24
Press releases
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
17 Apr 24
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership
4 Apr 24
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership
4 Apr 24
Laboratorio Barnafi-Krause is Live on SOPHiA DDM™
2 Apr 24
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada
20 Mar 24